VGI Health Technology (XNEC:VTL) General and Admin. Expense : A$ Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. VGI Health Technology's General and Admin. Expense for the six months ended in . 20 was A$0.00 Mil. VGI Health Technology does not have enough years/quarters to calculate the General and Admin. Expense for the trailing twelve months (TTM) ended in . 20.

VGI Health Technology General and Admin. Expense Historical Data

The historical data trend for VGI Health Technology's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology General and Admin. Expense Chart

VGI Health Technology Annual Data

Trend

General and Admin. Expense

VGI Health Technology Semi-Annual Data

General and Admin. Expense

VGI Health Technology General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

VGI Health Technology General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines